RESOURCES DIRECTORY

Organizations

Association of  American Medical Colleges (AAMC)

• Academic Medicine’s Response to the Opioid Crisis
• As drug overdoses soar, more providers embrace harm reduction
  (Feb 15, 2022)
• The Opioid Workforce Act of 2021 (S. 1438) (aamc.org)

Accreditation Council for Graduate Medical Education (ACGME)

• Opioid Use Disorder (acgme.org)

American Medical Association (AMA)

• AMA-Manatt Health 2022 State Policy Toolkit
• AMA-Manatt Health National Policy Roadmap
• AMA Substance Use and Pain Care Task Force Recommendations
• AMA 2022 Overdose Epidemic Report
• End the Epidemic: Data Dashboard
• One-pager: co-prescribing naloxone to patients at risk of overdose
• Issue Brief: The Nation’s Drugs Overdose Epidemic: Considerations for Employers
• Manatt/AMA Webinar on Telehealth Policies During COVID-19 and Substance Use Disorder Treatment
• State-by-state opioid prescription data 2011-2020
• Video: How to use naloxone
• Opioid Therapy and Pain Management CME: Guidelines, Research and Treatments | AMA Ed Hub (ama-assn.org)

American Hospital Association (AHA)

• Guidance highlights ADA protections for people with substance use disorders | AHA News
• Fentanyl and the Evolution of the Opioid Epidemic | AHA Events

American Osteopathic Association (AOA)

• FDA-Compliant Opioid Prescribing CME - American Osteopathic Association
• Group Based Opioid Treatment - American Osteopathic Association

American Society of Addiction Medicine (ASAM)

• American Society of Addiction Medicine Public Policy Statement on Advancing Racial Justice in Addiction Medicine (Feb 25, 2021)
• ASAM Pocket Guidelines and Patient Guide - ASAM Opioid Patient Guide 2020 (guidelinecentral.com)

Federation of State Medical Boards (FSMB)

• FSMB Opioids and Pain Management

Johns Hopkins Bloomberg School of Public Health

• Implementation tools to help states use opioid litigation funds for evidence-based programs

National Academy of Medicine (NAM)

• The 3Cs Framework for Pain and Unhealthy Substance Use: Minimum Core Competencies for Interprofessional Education and Practice - National Academy of Medicine (nam.edu)
• Chronic Pain Journey Map - National Academy of Medicine (nam.edu)
• Discussion Proceedings - Stigma of Addiction Summit - National Academy of Medicine (nam.edu)
• Methadone Treatment for Opioid Use Disorder: Examining Federal Regulations - Day 1 - National Academy of Medicine (nam.edu)
• Educating Together, Improving Together: Harmonizing Interprofessional Approaches to Address the Opioid Epidemic - National Academy of Medicine (nam.edu)
• Countering the Opioid Crisis: Time to Act Podcast - National Academy of Medicine (nam.edu)

National Council of State Boards of Nursing (NCSBN)

• NCSBN Opioid Toolkit

National Association of Boards of Pharmacy (NABP) 

• Drug Disposal Locator Tool and other disposal information for consumers
• Buying prescription medication safely online 
• Buying safely online communications kit for health care professionals 
• Rx Report Highlights Urgency of Acting on Opioid Crisis 
• How Fraudulent Online Drug Sellers Are Making the Opioid Epidemic Worse

Federal

Centers for Disease Control and Prevention (CDC)

• 2022 CDC Clinical Practice Guideline
• Summary of 2022 Clinical Practice Guideline
• Partner Toolkit for CDC Clinical Practice Guideline
• Data Overview | CDC's Response to the Opioid Overdose Epidemic | CDC
• CDC’s State Unintentional Drug Overdose Reporting System (SUDORS)
• Drug Overdose Deaths in the United States, 2001–2021
• Mortality Data on CDC WONDER
• Observations of the Opioid Workgroup of the Board of Scientific Counselors of the National Center for Injury Prevention and Control on the Updated CDC Guideline for Prescribing Opioids (July 2, 2021)
• Improve Opioid Prescribing | CDC's Response to the Opioid Overdose Epidemic | CDC
• Treat Opioid Use Disorder | CDC's Response to the Opioid Overdose Epidemic | CDC
• Reverse Overdose to Prevent Death | CDC's Response to the Opioid Overdose Epidemic | CDC
• CDC Opioid Resources and Tools

Centers for Medicare & Medicaid Services (CMS)

• CMS Selects Value in Opioid Use Disorder Treatment Demonstration Applicants (April 8, 2021)
• CMS Issues Guidance about Expanded Medicaid Coverage for Treatment of Opioid Use Disorders (Dec 30, 2020) 

United States Drug Enforcement Administration (DEA)

• DEA Finalizes Measures to Expand Medication-Assisted Treatment. (June 28, 2021) 

United States Department of Justice (DOJ)

• Justice Department Issues Guidance on Protections for People with Opioid Use Disorder under the Americans with Disabilities Act (April 5, 2022)

United States Government Accountability Office (GAO)

• Opioid Use Disorder: Treatment with Injectable and Implantable Buprenorphine | U.S. GAO
• Prescription Opioids: Patient Options for Safe and Effective Disposal of Unused Opioids | U.S. GAO

United States Department of Health and Human Services (HHS)

• HHS.gov/Opioids: The Prescription Drug & Heroin Overdose Epidemic | HHS.gov
• HHS Expands Access to Treatment for Opioid Use Disorder
  (Jan 14, 2021)
• Biden-Harris Administration Provides Nearly $1 Billion in American Rescue Plan Funds to Modernize Health Centers and Support Underserved Communities | HHS.gov
• HHS Guide for Clinicians on the Appropriate Dosage Reduction or Discontinuation of Long-Term Opioid Analgesics
• HHS Opioid Epidemic Practical Toolkit

Health Resources & Services Administration (HRSA)

• HRSA Opioid Crisis Resources

National Institutes of Health (NIH)

• Combination treatment for methamphetamine use disorder shows promise in NIH study (Jan 13, 2021)
• Opioid Overdose Deaths by Race/Ethnicity | KFF

Substance Abuse and Mental Health Services Administration (SAMHSA)

• SAMHSA Announces Unprecedented $30 Million Harm Reduction Grant Funding Opportunity to Help Address the Nation’s Substance Use and Overdose Epidemic (Dec 8, 2021)
• SAMHSA Extends the Methadone Take-Home Flexibility for One Year While Working Toward a Permanent Solution (Nov 18, 2021)
• Federal Guidelines for Opioid Treatment Programs | SAMHSA Publications and Digital Products
• Certification of Opioid Treatment Programs (OTPs) | SAMHSA
• Training Materials and Resources | SAMHSA
• Clinical Guidance for Treating Pregnant and Parenting Women With Opioid Use Disorder and Their Infants (samhsa.gov)

Office of National Drug Control Policy | The White House (ONDCP)

• The Biden-Harris Administration’s Statement of Drug Policy Priorities for Year One

United States Department of Agriculture (USDA)

• Opioid Resources | USDA